Catherine Berset

The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast <i>Saccharomyces cerevisiae</i>

Catherine Berset, Hans Trachsel, Michael Altmann · Proceedings of the National Academy of Sciences · 1998 · 138 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

Ross A. Soo, Ji‐Youn Han, Urania Dafni et al. · Annals of Oncology · 2021 · 116 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

RNA-binding activity of translation initiation factor eIF4G1 from <i>Saccharomyces cerevisiae</i>

Catherine Berset, Andreas Zurbriggen, Siamak Djafarzadeh et al. · RNA · 2003 · 69 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)

Christoph Driessen, Marianne Kraus, Markus Joerger et al. · Haematologica · 2015 · 58 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Yeast as a screening tool

Alcide Barberis, Tea Gunde, Catherine Berset et al. · Drug Discovery Today Technologies · 2005 · 55 citations

Life Sciences, Microbiology, Molecular Biology +10